| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 07/02/2002 | US6414038 Hydroxystilbenes for reducing/inhibiting protein glycation and combating skin aging |
| 07/02/2002 | US6414037 Pharmaceutical formulations of resveratrol and methods of use thereof |
| 07/02/2002 | US6414036 Composition for treatment of infections of humans and animals |
| 07/02/2002 | US6414035 Candida infections |
| 07/02/2002 | US6414034 Anticancer agents |
| 07/02/2002 | US6414033 Determination ph; buffer solution |
| 07/02/2002 | US6414032 Anti-infective compositions for treating disordered tissue such as cold sores |
| 07/02/2002 | US6414030 Use of benzenesulfonyl(thio)ureas for the treatment and prophylaxis of dysfunctions of the autonomous nervous system and use of benzenesulfonyl(thio)ureas in combination with beta-receptors blockers |
| 07/02/2002 | US6414029 Antidiabetic agents |
| 07/02/2002 | US6414028 Mixture with skin penetration intensifier, polysaccharide gum and buffer |
| 07/02/2002 | US6414027 Methods and compositions for treating male erectile dysfunction |
| 07/02/2002 | US6414026 Compounds which interact with the thyroid hormone receptor for the treatment of fibrotic disease |
| 07/02/2002 | US6414025 Rheumatic disorders; antiinflammatory agents; autoimmune diseases |
| 07/02/2002 | US6414024 GABA and L-glutamic acid analogs for antiseizure treatment |
| 07/02/2002 | US6414023 Disinfecting composition |
| 07/02/2002 | US6414022 Cyclopentane(ENE)heptenoic or heptenoic acids and derivatives thereof useful as therapeutic agents |
| 07/02/2002 | US6414021 Vision defects |
| 07/02/2002 | US6414020 Antiproteolytic amidino or derivative useful for treating pencreatitis, thrombosis, ischemia, stroke, restenosis, emphysema or inflammation |
| 07/02/2002 | US6414018 Heart surgery; electricity pacing; administering adrenergic blocking agent |
| 07/02/2002 | US6414017 Inhibition of hair growth |
| 07/02/2002 | US6414016 Anti-constipation composition |
| 07/02/2002 | US6414015 Antiproliferative agents |
| 07/02/2002 | US6414014 Calibration dosage; side effect reduction |
| 07/02/2002 | US6414013 Thiophene compounds, process for preparing the same, and pharmaceutical compositions containing the same background of the invention |
| 07/02/2002 | US6414012 Heterocyclic derivatives, method of production thereof and pharmaceutical use thereof |
| 07/02/2002 | US6414011 Central nervous system disorders |
| 07/02/2002 | US6414009 Cardiovascular disorders; anticoagulants |
| 07/02/2002 | US6414006 Methods for inhibiting bone resorption |
| 07/02/2002 | US6414004 3-substituted 5-aryl-4-isoxazolecarbonitriles having antiviral activity |
| 07/02/2002 | US6414003 Antiulcer agents |
| 07/02/2002 | US6414001 Ether and amide compounds preparation thereof composition containing same and use thereof as antidiadetics |
| 07/02/2002 | US6413999 Administering 2-oxothiazolidone-4-carboxylate; antiinflammatory agent |
| 07/02/2002 | US6413998 Compositions and methods for treating bone deficit conditions |
| 07/02/2002 | US6413996 Diaminocyclobutene-3,4-dione derivatives, their preparation and use |
| 07/02/2002 | US6413994 Modulating insulin sensitivity and blood glucose concentration |
| 07/02/2002 | US6413993 Combination preparation for treating malaria |
| 07/02/2002 | US6413991 Antidiabetic agents; dietetics |
| 07/02/2002 | US6413989 Piperidinylmethyloxazolidinone derivative |
| 07/02/2002 | US6413988 Prucalopride oral solution |
| 07/02/2002 | US6413987 Dermal anesthetic agents |
| 07/02/2002 | US6413986 [1-indanon-2-yl]methylpiperidines |
| 07/02/2002 | US6413985 Selective antagonists for the strychnine insensitive glycine binding site associated with the nmda receptor complex. |
| 07/02/2002 | US6413984 8-(heterocyclylmethyl)quinoline derivatives for treating urinary incontinence |
| 07/02/2002 | US6413982 4-substituted quinoline derivatives |
| 07/02/2002 | US6413981 Drug-resistant gram positive and gram negative bacteria; pneumonia; infections of upper and lower respiratory tract, skin, soft tissue, bones and joints |
| 07/02/2002 | US6413980 Nitrogen containing heterobicycles as factor Xa inhibitors |
| 07/02/2002 | US6413979 Substituted 5-(2,2-difluoro-1,3-benzodioxol-5-yl) cyclopentenopyridine derivative |
| 07/02/2002 | US6413978 Basic derivatives of benz[e] isoindol-1-ones and pyrrolo[3,4-c] quinolin-1-ones with 5-HT3-antagonistic activity, their preparation and their therapeutic use |
| 07/02/2002 | US6413977 Chromeno[4,3,2-DE]isoquinolines as potent dopamine receptor ligands |
| 07/02/2002 | US6413976 Compositions and method for decreasing neuropathic pain |
| 07/02/2002 | US6413975 Purine derivatives having phosphodiesterase iv inhibition activity |
| 07/02/2002 | US6413972 5,8-dihydro-3-methyl-5-oxo-8-(1-oxo-1-phenyl-2-propyl)-2 -phenylimidazo(1,2-a)pyrimidine-6-carboxylic acid ethyl ester; gonadotropin-releasing hormone antagonizing activity; low toxicity; anticarcinogenic agent; contraceptive |
| 07/02/2002 | US6413971 Antiproliferative, -carcinogenic, -tumor and -diabetic agents; binding to or modulating the human kinase insert-domain-containing receptor (kdr) or the murine fetal liver kinase 1 (flk-1) receptor; vasculogenesis; angiogenesis |
| 07/02/2002 | US6413970 Pharmaceutical composition for treating viral diseases |
| 07/02/2002 | US6413969 Gatifloxacin pentahydrate |
| 07/02/2002 | US6413968 Sildenafil; alleviation of complications such as diplopia and ptosis; once to four times daily oral administration; does not act as an anticholinesterase agent; eyes |
| 07/02/2002 | US6413967 Inhibition of novel calcium entry pathway in electrically non-excitable cells acting as an anti-proliferative therapy |
| 07/02/2002 | US6413966 Serotonergic and central dopaminergic activity; affinity for 5ht1a and 5ht2 serotonin and d2 dopamine receptors; atypical antipsychotics; schizophrenia |
| 07/02/2002 | US6413965 Selective cox-2 and an aldose reductase inhibitor; neuropathy, nephropathy, retinopathy and cardiomyopathy; avoiding side effects such as gastric and renal toxicity |
| 07/02/2002 | US6413963 Alpha, beta-integrin inhibitors used in the treatment of multiple sclerosis, atherosclerosis, asthma and inflammatory bowel disease |
| 07/02/2002 | US6413962 Anesthesia and temperatures reduction; alpha-adrenoceptor agonist; restorative to central nervous system, especially motor and sensory functional losses from tramatic spinal cord injuries; antispastics; nonsedative; side effect reduction |
| 07/02/2002 | US6413961 Perioperative delivery to surgical site of local anesthetic and other medicants; lower doses; anti-restenosis; anti-spasmotic; arthroscopy; cardiovascular and general vascular operations |
| 07/02/2002 | US6413960 Substituted pyrazolyl benzenesulfonamides for the treatment of asthma |
| 07/02/2002 | US6413958 For treatment/prevention of infection of herpes simplex virus, varicella zoster virus, human cytomegalovirus, or epstein-barr virus; enzyme inhibitors |
| 07/02/2002 | US6413957 Methods of inhibiting cell proliferation using indeno [1,2-c]pyrazol-4-ones |
| 07/02/2002 | US6413956 Substituted 4-oxo-quinoline-3-carboxamides |
| 07/02/2002 | US6413955 1,8-naphthyridines or 5-thio-1,8-naphthyridines or 5-oxo-1,8-naphthyridines; bone resorption, osteoporosis, vascular rest-enosis, diabetic retinopathy, macular degeneration, angio-genesis, atherosclerosis, inflammatory arthritis, cancer |
| 07/02/2002 | US6413953 Amine(chloro)trihydroxo(2-methylpyridine)platinum(iv); water solubility; single or combined therapy with gemcitabine, etoposide or taxol or radiotherapy; diminished side effects; improved bioavailability; anticancer agent; ovarian cancer |
| 07/02/2002 | US6413952 Agonizing dimeric cell-surface receptors with a receptor binding moiety and chelating metal |
| 07/02/2002 | US6413950 Topical application; skin disorders |
| 07/02/2002 | US6413949 Prodrugs with enhanced penetration into cells |
| 07/02/2002 | US6413948 Central nervous system disorders |
| 07/02/2002 | US6413946 Using fosfomycin and vanadium compound |
| 07/02/2002 | US6413945 Gastro-specific prodrugs |
| 07/02/2002 | US6413944 Retroviral therapy |
| 07/02/2002 | US6413941 Polymer composition for delivering a nucleic acid or derivative thereof |
| 07/02/2002 | US6413940 Pharmaceutically active agents that impede the formation of amyloid by impeding the genesis of DMS |
| 07/02/2002 | US6413939 Inducible phosphofructokinase and the Warburg effect |
| 07/02/2002 | US6413938 Herpes virus |
| 07/02/2002 | US6413936 Glycomimetics as selectin antagonists and pharmaceuticals having antiinflammatory activity |
| 07/02/2002 | US6413932 Tek antagonists comprising soluble tek extracellular binding domain |
| 07/02/2002 | US6413930 Controlling eye movement |
| 07/02/2002 | US6413773 Phosphatidylinositol 3-kinase inhibitors as stimulators of endocrine differentiation |
| 07/02/2002 | US6413762 Viral nucleotide sequences |
| 07/02/2002 | US6413756 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
| 07/02/2002 | US6413740 Nucleic acid which codes for muscle specific kinase c-terminal fragment of human agrin; diagnosis and treatment of muscle disorders and neuromusclar disorders |
| 07/02/2002 | US6413735 Method of screening for a modulator of angiogenesis |
| 07/02/2002 | US6413731 Methods of screening for compounds which bind to a human SNORF36A receptor |
| 07/02/2002 | US6413558 Compositions, kits, and methods for providing and maintaining energy and metal alertness |
| 07/02/2002 | US6413552 Topically applied creatine containing composition |
| 07/02/2002 | US6413550 Proteinoid carriers and methods for preparation and use thereof |
| 07/02/2002 | US6413549 Freeze drying |
| 07/02/2002 | US6413545 Administering mixture containing plant extracts; appetite suppressant |
| 07/02/2002 | US6413542 Topical solution of a pyrazole compound of given formula; controlling ticks: elimination of boophilus microplus in less than 2 days, for cattle, sheep |
| 07/02/2002 | US6413540 For eyes |
| 07/02/2002 | US6413537 Nystatin formulation having reduced toxicity |
| 07/02/2002 | US6413535 Administering chlorinated phenyl compound |
| 07/02/2002 | US6413534 Administering chlorinated phenyl compound |
| 07/02/2002 | US6413533 Administering antiestrogen |
| 07/02/2002 | US6413524 spsA polynucleotides and polypeptides |